Native High-resolution 3D SSFP MR Angiography for Assessment of the Thoracic Aorta in Pregnant Subjects With Familial Aortopathies
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 15
- Locations
- 1
- Primary Endpoint
- Gestation at delivery
Study Overview
Brief Summary
Introduction: Native magnetic resonance angiography (MRA) is recommended to assess the thoracic aorta during pregnancy, avoiding the risks of ionising radiation and contrast agent administration. This guidance is however, based only on consensus opinion supported by limited case reports (level of evidence C).
Aim: To evaluate the feasibility of performing native 3D steady-state free-precession (SSFP) MRA in pregnant subjects with inherited aortopathy to guide timing and mode of delivery.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Any pregnant subject with a history of familial aortopathy
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Gestation at delivery
Time Frame: 40 weeks
Completion of non-contrast 3D MRA aorta
Time Frame: 40 weeks
Secondary Outcomes
No secondary outcomes reported
Investigators
William E Moody
SpR Cardiology
University Hospital Birmingham NHS Foundation Trust
